What this means
Researchers plan to test a program that mixes thinking exercises, social activity, and goal setting. This trial has not reported results yet, so it cannot yet show whether the program works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60–75
- Where
- 1 site
The science
- Registered title
- Validation of the REMINDER Dementia Risk Reduction Program
- Trial ID
- NCT05296980 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Healthy Aging, Risk Reduction, Old Age; Dementia
- What is tested
- REMINDER, Brain health Psychoeducation
- Sponsor
- University of Coimbra
- Ages
- 60 Years to 75 Years
- Dates
- First posted Mar 25, 2022 · updated May 8, 2024
Registry summary
Until now, neuropsychological interventions aimed to optimize cognitive function and to have functional impact in individuals at risk of AD (MCI patients) were scarce in validity studies. While some RCTs have been developed in cognitive training interventions, comparative studies of merged interventions (cognitive, social and behavioral stimulation) with adequate control groups are absent, diminishing the professionals' trust on the adoption of these interventions for supporting patients. As such, the present proposal will develop a validation trial testing a multicomponent neuropsychological intervention (REMINDER), based on personal development, cognitive compensatory aids, meaningful goals setting, and behavior change techniques. The investigators will analyze its short/long-term gains and AD conversion rates. By aiming to provide a good validation study for REMINDER, the investigators will examine neurobiological, neurocognitive and functional outcomes of this intervention in comparison with an active control group (psychoeducation) in order to foster an effective outcome assessment of an intervention for individuals at risk of AD.
Sites (1)
- Faculty of Psychology and Educational Sciences, Coimbra, Portugal